Proleukin interleukin-2 data

Long-term follow-up of patients from a Phase I/II trial was reported at the American Society of Clinical Oncology meeting in Los Angeles, showing survival with reduced tumor size.

Seven of 34 evaluable patients had complete responses (confirmed by laparotomy) and there were two partial responses. Six patients are still alive and free of tumors after more than five years. ...